Physician profile
Raphael Cooper
NPI 1811989890
$7,275.64
in general payments reported to CMS, 2019-2025
39 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $457 · 2021: $713 · 2022: $1,486 · 2023: $682 · 2024: $1,062 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,600 · Education: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.90 |
| Education | $359.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,461.57 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $923.13 | 2019-2025 | Erleada, Akeega, Balversa |
| Bayer Healthcare Pharmaceuticals INC. | $697.78 | 2019-2025 | |
| Pfizer INC. | $506.41 | 2019-2025 | |
| Coloplast Corp | $478.38 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $395.76 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $349.03 | 2019-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $274.00 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $241.14 | 2019-2024 | Xiaflex, Edex, Aveed |
| Dendreon Pharmaceuticals LLC | $227.21 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $201.87 | 2022-2025 | Myrisk, Prolaris |
| Urovant Sciences INC | $173.17 | 2021-2022 | |
| Rochester Medical Corporation | $155.42 | 2019-2022 | |
| Urogen Pharma, INC. | $142.38 | 2021-2025 | |
| Dentsply Ih INC. | $117.28 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.